Bryan K. Chan
Harbor–UCLA Medical Center · 42 works · 2,648 citations · h-index 15
Top works
- Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
- Decoding global gene expression programs in liver cancer by noninvasive imaging
- Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
- Telemedicine for the Medicare population.
- Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
- Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition
- Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
- Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation
- Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer
- Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)
- Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
- Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor
- Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR
- Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor
- Discovery of GNE-6893, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of HPK1
- Small Molecules for Cancer Immunotherapy
- Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study
- Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration
- Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2
- Optimization of Brain Penetrant SARM1 Orthosteric Inhibitors and Discovery of Their Paradoxical Subinhibitory Activation